Literature DB >> 12495679

Infections in a burn intensive care unit: experience of seven years.

S G Santucci1, S Gobara, C R Santos, C Fontana, A S Levin.   

Abstract

The objective of this study is to describe infections in a specialized burns intensive care unit from 1993 to 1999. The criteria for admission to the unit are: children with burns involving at least 10% or adults with burns involving at least 20% of total body surface; burns affecting face, perineum or feet; suspected or proven airway injury; electric or chemical burns; age less than one year or above 50; or pre-existing disease with any extent of burns. Surveillance of hospital-acquired infection was prospective. Hospital-acquired infection criteria used were those modified from the Centers for Disease Control and Prevention. Diagnosis of infection using skin biopsy was not done. Over the study period, 320 patients were admitted to our burns intensive care unit. One hundred and seventy-five (55%) developed 388 hospital-acquired infections. The rate for vascular catheter-associated bloodstream infections was 34 per 1,000 central line-days. The rate of ventilator associated pneumonia was 26 infections per 1,000 ventilator-days. Primary bloodstream was the most common infection with 189 episodes (49%); followed by 83 burn wound infections (21%) and 56 pneumonias (14%). In 76% of these infections and in 97% of the primary bloodstream infections, aetiological agents were identified. The micro-organisms causing infections were S taphylococcus aureus (24%), Pseudomonas aeruginosa (18%), Acinetobacter spp. (14%) and coagulase-negative staphylococci (12%). Candida spp. caused 8% of infections. Gram-positive and Gram-negative organisms exhibited resistance to most antimicrobial agents used for therapy. During the first three days of hospitalization in the burns intensive care unit there were eight infections caused by S. aureus and three of these were resistant to oxacillin. These data provide background information regarding extensive burn patients on which decisions for control and prevention of hospital-acquired infections can be made.

Entities:  

Mesh:

Year:  2003        PMID: 12495679     DOI: 10.1053/jhin.2002.1340

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  56 in total

1.  Prior thermal injury accelerates endotoxin-induced inflammatory cytokine production and intestinal nuclear factor-κB activation in mice.

Authors:  Nathan L Huber; Stephanie R Bailey; Rebecca Schuster; Cora K Ogle; Alex B Lentsch; Timothy A Pritts
Journal:  J Burn Care Res       Date:  2012 Mar-Apr       Impact factor: 1.845

2.  [Not Available].

Authors:  Jf Arnould; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-03-31

3.  Topical p38 MAPK inhibition reduces bacterial growth in an in vivo burn wound model.

Authors:  Kyros Ipaktchi; Aladdein Mattar; Andreas D Niederbichler; Laszlo M Hoesel; Sabrina Vollmannshauser; Mark R Hemmila; Rebecca M Minter; Grace L Su; Stewart C Wang; Saman Arbabi
Journal:  Surgery       Date:  2007-07       Impact factor: 3.982

4.  Real-Time Prediction for Burn Length of Stay Via Median Residual Hospital Length of Stay Methodology.

Authors:  Sandra L Taylor; Soman Sen; David G Greenhalgh; MaryBeth Lawless; Terese Curri; Tina L Palmieri
Journal:  J Burn Care Res       Date:  2016 Sep-Oct       Impact factor: 1.845

Review 5.  Fungal infections in burns: a comprehensive review.

Authors:  M F Struck; J Gille
Journal:  Ann Burns Fire Disasters       Date:  2013-09-30

6.  Antiseptics for burns: a review of the evidence.

Authors:  L Slaviero; G Avruscio; V Vindigni; I Tocco-Tussardi
Journal:  Ann Burns Fire Disasters       Date:  2018-09-30

7.  Infectious complications in adult burn patients and antimicrobial resistance pattern of microorganisms isolated.

Authors:  E F Zampar; E H T Anami; G Kerbauy; L F T Queiroz; C M D M Carrilho; L T Q Cardoso; C M C Grion
Journal:  Ann Burns Fire Disasters       Date:  2017-12-31

8.  Expression analysis of the Pseudomonas aeruginosa AlgZR two-component regulatory system.

Authors:  Christopher L Pritchett; Alexander S Little; Yuta Okkotsu; Anders Frisk; William L Cody; Christopher R Covey; Michael J Schurr
Journal:  J Bacteriol       Date:  2014-12-08       Impact factor: 3.490

Review 9.  Nanofibers offer alternative ways to the treatment of skin infections.

Authors:  T D J Heunis; L M T Dicks
Journal:  J Biomed Biotechnol       Date:  2010-07-28

10.  Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury.

Authors:  John F Mohr; Luis Ostrosky-Zeichner; David J Wainright; Donald H Parks; Timothy C Hollenbeck; Charles D Ericsson
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.